TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/21 20:12 | 5/13/21 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Slacik Charles P | CA | D | S.d | -113 | 113.26 | 0 | -1 | -8 | 12 | D | |||||||||||||||
11/6/20 19:16 | 11/5/20 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Slacik Charles P | CA | D | S.d | -1,132 | 282.46 | 0 | -4 | -26 | 11 | D | |||||||||||||||
5/22/19 20:02 | 5/20/19 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Slacik Charles P | CA | D | S | -55 | 55.19 | 0 | -1 | -10 | 9 | D | |||||||||||||||
8/14/18 20:03 | 8/10/18 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Slacik Charles P | CA | D | S | -68 | 68.28 | 0 | -1 | -11 | 8 | D | |||||||||||||||
1/6/09 20:05 | 1/5/09 | BEC | Beckman Coulter Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Slacik Charles P | CA | O | SVP,CFO | S | -13 | 44.32 | 0 | 0 | -2 | 16 | |||||||||||||||
11/2/07 20:36 | 10/25/07 | BEC | Beckman Coulter Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Slacik Charles P | CA | O | SVP,CFO | S | -170 | 71.55 | 0 | -2 | -18 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |